ITK
Tyrosine-protein kinase ITK/TSK
Also known as: EMT, ITK_HUMAN, LYK, PSCTK2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q08881
- Gene
- ITK
- Ensembl
- ENSG00000113263
- Chromosome
- 5
- Canonical length
- 620 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
This gene encodes an intracellular tyrosine kinase expressed in T-cells. The protein contains both SH2 and SH3 domains which are often found in intracellular kinases. It is thought to play a role in T-cell proliferation and differentiation. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
620 residues, UniProt reviewed canonical sequence.
>Q08881|ITK
1 MNNFILLEEQ LIKKSQQKRR TSPSNFKVRF FVLTKASLAY FEDRHGKKRT LKGSIELSRI
61 KCVEIVKSDI SIPCHYKYPF QVVHDNYLLY VFAPDRESRQ RWVLALKEET RNNNSLVPKY
121 HPNFWMDGKW RCCSQLEKLA TGCAQYDPTK NASKKPLPPT PEDNRRPLWE PEETVVIALY
181 DYQTNDPQEL ALRRNEEYCL LDSSEIHWWR VQDRNGHEGY VPSSYLVEKS PNNLETYEWY
241 NKSISRDKAE KLLLDTGKEG AFMVRDSRTA GTYTVSVFTK AVVSENNPCI KHYHIKETND
301 NPKRYYVAEK YVFDSIPLLI NYHQHNGGGL VTRLRYPVCF GRQKAPVTAG LRYGKWVIDP
361 SELTFVQEIG SGQFGLVHLG YWLNKDKVAI KTIREGAMSE EDFIEEAEVM MKLSHPKLVQ
421 LYGVCLEQAP ICLVFEFMEH GCLSDYLRTQ RGLFAAETLL GMCLDVCEGM AYLEEACVIH
481 RDLAARNCLV GENQVIKVSD FGMTRFVLDD QYTSSTGTKF PVKWASPEVF SFSRYSSKSD
541 VWSFGVLMWE VFSEGKIPYE NRSNSEVVED ISTGFRLYKP RLASTHVYQI MNHCWKERPE
601 DRPAFSRLLR QLAEIAESGLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ITK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 54 nTPM
Expression across tissuesHPA
Tissue
- thymus: 54 nTPM
- lymph node: 27 nTPM
- tonsil: 23 nTPM
- appendix: 15 nTPM
- spleen: 9.8 nTPM
- gallbladder: 4 nTPM
Single-cell type
- t-cells: 564 nCPM
- nk-cells: 295 nCPM
- innate lymphoid cells: 136 nCPM
- mast cells: 125 nCPM
- early spermatids: 74 nCPM
- thymocytes: 23 nCPM
Immune cell
- naive CD4 T-cell: 78 nTPM
- T-reg: 70 nTPM
- naive CD8 T-cell: 64 nTPM
- memory CD4 T-cell: 56 nTPM
- memory CD8 T-cell: 54 nTPM
- total PBMC: 44 nTPM
Brain region
- thalamus: 0.1 nTPM
- white matter: 0.1 nTPM
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ITK.
Disease | AllUniProt
Conditions ITK is implicated in, by any mechanism.
- Lymphoproliferative syndrome 1 (LPFS1) MIM:613011
Disease | GeneticClinVar
22 pathogenic / likely-pathogenic of 621 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Lymphoproliferative syndrome 1
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.71
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.53
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- B cell receptor signaling pathway
- cellular defense response
- gamma-delta T cell activation
- intracellular signal transduction
- NK T cell differentiation
- positive regulation of cytokine production
- signal transduction
- T cell activation
- T cell receptor signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- SH2 domain
- Serine-threonine/tyrosine-protein kinase, catalytic domain
- SH3 domain
- Zinc finger, Btk motif
- Pleckstrin homology domain
- Tyrosine-protein kinase, active site
- Protein kinase-like domain superfamily
- PH-like domain superfamily
- Protein kinase, ATP binding site
- Tyrosine-protein kinase, catalytic domain
- SH3-like domain superfamily
- SH2 domain superfamily
- Non-receptor tyrosine kinases involved in cell signaling
- SH2 domain
- SH3 domain
- PH domain
- BTK motif
- Protein tyrosine and serine/threonine kinase
- Tyrosine-protein kinase ITK, SH3 domain
- Tyrosine-protein kinase ITK/TSK, catalytic domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ITK in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ITK as an antibody target. Whether an autoantibody or antibody against ITK could matter depends on whether native ITK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ITK is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ITK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...